Rare diseases
Investigational molecules
Locations
Back to Bulgaria111 clinical trials in Haskovo, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
A Phase 2 Study of LAD603 in Adults with Systemic Lupus Erythematosus and Active Skin Rash
BulgariaEfficacy and Safety of Letrozole SIE Compared with Oral Letrozole, Both with Ribociclib, in Postmenopausal Women with HR‑Positive, HER2‑Negative Metastatic Breast Cancer
BulgariaELV001 for Active Rheumatoid Arthritis in Patients with Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition
BulgariaA study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis
BulgariaA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
BulgariaComparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis
BulgariaStudy of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis
BulgariaStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
BulgariaStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
BulgariaLong-Term Safety Study of Plozasiran for Adults with High Triglycerides
BulgariaStudy on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Asthma in Patients Aged 12 and Older
BulgariaStudy of ISIS 678354 for Patients with Severe High Triglycerides
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Studies focusing on cardiovascular health and prevention, including trials evaluating new treatments for heart failure and atherosclerotic disease. Research emphasizes preventive measures and therapeutic interventions.
Multiple innovative therapies being tested to reduce cardiovascular events and improve patient outcomes.
Comprehensive research into respiratory conditions, with particular emphasis on COPD and asthma management. Studies evaluate both single and combination therapies.
Focus on improving lung function and reducing disease exacerbations through novel therapeutic approaches.
Investigation of treatments for various autoimmune conditions, including lupus, rheumatoid arthritis, and psoriasis. Research aims to develop targeted therapies.
Studies evaluate long-term safety and efficacy of new biological treatments.
Advanced research in cancer treatment, particularly focusing on breast cancer and various solid tumors. Studies include both single-agent and combination therapies.
Innovative approaches in targeting specific cancer pathways and managing treatment side effects.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
